avateramedical N.V. (the Company) invites its shareholders to its Annual General Meeting of Shareholders (AGM) to be held at WTC Schiphol, TOO Office Center, G tower, Schiphol-Airport (Haarlemmermeer), the Netherlands, on 15 July 2019, at 10:00 hours CET. The language of the meeting shall be in English.
The agenda items of the AGM will be as follows:
(1) Opening of the meeting
(2) Business Update (discussion item)
(3) Annual Report for the financial year 2018 (discussion item)
(4) Adoption of the annual accounts for the financial year 2018 (voting item)
(5) Release of liability to the members of the Management Board of the Company for the financial year 2018 (voting item)
(6) Release of liability to the members of the Supervisory Board of the Company for the financial year 2018 (voting item)
(7) Appointment of the external accountant for the financial year 2019 (voting item)
(8) Closing of the meeting
The explanatory notes to the agenda and a form of written proxy are available for inspection and can be obtained free of charge at the offices of the Company. The explanatory notes and a form of written proxy are available at the Company's website (http://investor.avateramedical.com/start/) as well.
Holders of bearer shares intending to attend the AGM in person or by proxy are asked to deposit their shares against receipt of a certificate of deposit not later than on one business day prior to the AGM.
The deposit of the bearer shares means that the bearer shares held by the shareholder in his securities account are blocked from trading, and as such held in deposit by the shareholder’s bank until (and including) the date of the AGM. A copy of the certificate of deposit may be sent not later than on 12 July 2019 at 17:00 hours CET, by e-mail to henrike.eckhardt@
Voting by Proxy
The right to attend and to vote at the meeting may be exercised by a written proxy. A form of a written proxy is available at the Company's offices and is available at the Company's website (http://investor.avateramedical.com/start/) as well. The proxy to represent a shareholder may (but needs not) be granted to Dr H.E.H. von Grünberg, by sending an email with proxy and voting instructions to henrike.eckhardt@
As at 28 June 2019 the issued share capital of the Company amounts to EUR 24,221,041.70, divided into 242,210,417 ordinary shares of EUR 0.10 each.
In case of any questions or comments in relation to the AGM, please refer to Dr H.E.H. von Grünberg (hubertus.gruenberg-von@
The Management Board of avateramedical N.V.,
Dr Hubertus von Grünberg